Trial Profile
Phase I/II Double Blind Randomized Trial of Lenalidomide/Dexamethasone/Anakinra vs. Lenalidomide/Dexamethasone/Placebo in Patients With Early Stage Multiple Myeloma and High Plasma Cell Growth Rate
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Mar 2020
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Dexamethasone; Lenalidomide
- Indications Smoldering multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2019 Status changed from active, no longer recruiting to completed.
- 05 Jun 2019 Planned End Date changed from 1 Jul 2020 to 15 Jul 2020.
- 05 Jun 2019 Status changed from suspended to active, no longer recruiting.